| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bleznick Jordan serves as a Director at ENZN. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $15K at current prices.
The biggest single holding is ENZN (~$15K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 100,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2020 | ENZN Enzon Pharmaceuticals, Inc. | Director | Buy | 100,000 | $0.15 | $15,380.00 | New |